This week, Vinay and Jeremy pay tribute to their robot overlords and dive into recent announcements from OpenAI, Anthropic, and others as they discuss and debate the future of AI in healthcare.

Jeremy and Vinay look back at the rapid evolution of GLP-1s over the past year, including updates on the latest science, new drugs in development, and purchasing options for consumers and employer health plans.

Guest Sally Pace, CEO of the Connect Healthcare Collaboration (CHC) and creator of the Granite List, joins us for a conversation on her background, helping employees understand healthcare benefits, and the superiority of Memphis musicians.

This episode's explainer: What is Medicare Advantage? A timely topic given that United Health Group is being investigated by the DOJ for potential MA fraud, according to a recent WSJ report. Also on this episode: the measles outbreak in Texas.

Vinay and Jeremy discuss Aetna suing pharmaceutical companies, updates on avian flu and CDC communications, and healthcare predictions for 2025. Plus -- an all-important update on the escaped lab monkeys.

Please note that this episode includes information around CDC communication and avian flu that was accurate at the time of recording, but has since changed by the time of episode publication. We will address these inaccuracies openly in our next episode.

In this episode, Vinay and Jeremy talk to benefits and risk consultant Phil Harrison of Healthcare Reporting about the evolution of health plans and consumerism, transparency in benefits consulting, and the fiduciary responsibility of health plan consultants and sponsors. It's a fascinating discussion on the changing industry from the viewpoint of an experienced consultant and fiduciary; don't miss it!